Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: April 2009
Seroquel XR approved for treatment of bipolar disorder
01 April 2009 | New Clinical Evidence
Seroquel XR approved in Ireland for new indications for the treatment of bipolar disorder.... Read more
Epilim approved for treatment and prevention of mania
01 April 2009 | New Clinical Evidence
Epilim prolonged release approved for the treatment and prevention of mania associated with bipolar disorders... Read more
Actavis Epirubicin
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Epirubicin 2mg/ml. Description: Solution for injection. Presentation: 5ml, 25ml vials; prices available on request. Indications: Epirubicin is used in the treatment of a range of neoplastic conditions including carcinoma... Read more
Actavis Gemcitabine
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Gemcitabine (as HCl) 200mg, 1g. Description: Concentrate for solution for infusion. Presentation: 2ml or 5ml vial; prices available on request. Indications: Locally advanced or metastatic bladder cancer in combination... Read more
Actavis Irinotecan
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Irinotecan HCl trihydrate 20mg/ml equivalent to irinotecan 17.33mg/ml. Description: Concentrate for solution for infusion. Presentation: 2ml or 5ml vial; prices available on request. Indications: Advanced colorectal cancer, in combination... Read more
Actavis Paclitaxel
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Paclitaxel 6mg/ml. Description: Concentrate for solution for infusion. Presentation: 5ml; 16.7ml; 25ml or 50ml vial; prices available on request. Indications: Ovarian cancer: First-line treatment of advanced ovarian cancer or... Read more
Alendronic Acid Bentley
01 April 2009 | New Products
Company: Bentley Pharmaceuticals Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Alendronic acid 70mg. Description: White oval flat tablets marked 70 on one side. Presentation: 4, €14.33. Indication: Postmenopausal osteoporosis. Sodium alendronate reduces the risk of vertebral and... Read more
Bellcital
01 April 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Citalopram hydrobromide eq. to citalopram 10mg, 20mg. Description: White to off-white circular biconvex film-coated tablets debossed with strength on one side and the other side respectively plain or with... Read more
Bellisin
01 April 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Lisinopril (as dihydrate) 10mg, 20mg. Description: Uncoated tablets debossed with strength on one side and plain on the other. Light yellow coloured and biconvex capsule-shaped (10mg); light peach coloured... Read more
Bellramil
01 April 2009 | New Products
Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ramipril 2.5mg, 5mg, 10mg. Description: Size 4 hard capsule with, respectively, yellow, orange, maroon or blue cap /white body, imprinted with R on cap and strength on body. Contain... Read more
Bellsert
01 April 2009 | New Products
Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Sertraline 50mg, 100mg. Description: White film-coated caplet shaped tablet embossed with strength on one side and break-line on the other. Presentation: 50mg-28, €20.57; 100mg-28, €30.69. Indication: Major depressive episodes.... Read more
Bellvirax
01 April 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Aciclovir 200mg, 800mg. Description: Capsule-shaped biconvex uncoated white to off-white tablets with strength embossed one side and ACV the other. Presentation: 200mg-25, €21.50; 800mg-35, €65.43. Indications: Treatment of herpes... Read more
Bellzac
01 April 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fluoxetine 20mg (as hydrochloride). Description: Green/off white hard gelatine self locked size 2 capsules containing white powder, imprinted with R/FXT 20 on cap/body in black edible ink. Presentation: 20mg-30,... Read more
Bisop
01 April 2009 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Prohibited in specific sports. Active ingredient: Bisoprolol fumarate 1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, 10mg. Description: Round film-coated tablet encoded BIS and strength on one side. White (2.5mg), yellow-white with a score (3.75mg), yellow... Read more
Clarithromycin Ranbaxy
01 April 2009 | New Products
Company: Ranbaxy Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clarithromycin 250mg, 500mg. Description: Light yellow, oval shaped biconvex film-coated tablet, embossed with C1 on one side (250mg) or embossed with C and 2 on either side of a... Read more
Donecept
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil (hydrochloride) 5mg, 10mg. Description: Round and biconvex film-coated tablet marked with DZ 5 and DZ 10 respectively. 5mg white, 10mg pale yellow. Presentation: Prices available on request.... Read more
Finasteride Ranbaxy
01 April 2009 | New Products
Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Finasteride 5mg. Description: White, round, biconvex, film-coated tablet, diameter 7 mm, embossed F and 5 on one side. Presentation: 28, €17.88. Indications: Treatment and control of benign prostatic hyperplasia... Read more
Lansoprazole Bentley
01 April 2009 | New Products
Company: Bentley Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sports permitted. Active ingredient: Lansoprazole 15mg, 30mg. Description: White opaque capsules marked L on cap and strength on body, filled with gastro-resistant micropellets. Presentation: 15mg-28, €9.90; 30mg-28, €19.67. Indications: Duodenal ulcer, benign... Read more
Mirtazapine TEVA
01 April 2009 | New Products
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Mirtazapine 15mg, 30mg, 45mg. Description: Round, white, bevelled edge tablets marked 93 on one side and 7303, 7304 or 7305, respectively, on the other. Presentation: 15mg-30, €9.84; 30mg-30,... Read more
Omeprazole Bentley
01 April 2009 | New Products
Company: Bentley Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Omeprazole 10mg, 20mg, 40mg. Description: Opaque capsules marked O followed by strength containing gastro-resistant granules. 10mg, red/orange; 20mg and 40mg, blue/orange. Presentation: 10mg-28, €11.05; 20mg-28, €17.99; 40mg-14, €18.84.... Read more
Percarnil
01 April 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Perindopril (tert-butylamine salt) 4mg, 8mg, equivalent to perindopril 3.338mg and 6.676mg. Description: White, oblong tablet, with a break-line on both sides, PP engraved on one side and 4... Read more
Simvastatin Bentley
01 April 2009 | New Products
Company: Bentley Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Simvastatin 10mg, 20mg, 40mg. Description: Oval, biconvex, film-coated tablets. 10mg: Peach scored marked 0 on each side of the scoreline. Respectively tan-coloured marked 20 or brick red marked... Read more
Creon 40000 Capsules
01 April 2009 | New Presentations
Company: Solvay Healthcare Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Pancreatin 400mg equivalent to lipase 40,000, amylase 25,000, protease 1,600 PhEur units. Description: Brown/clear hard gelatin capsule containing light brown, gastro-resistant granules. Presentation: 100-€56.92. Indication: For the treatment... Read more
Epilim Chronosphere
01 April 2009 | New Presentations
Prescription.GMS. Sport Permitted Sanofi-aventis is pleased to announce that Epilim (sodium valproate) Chronosphere prolonged release granules are now available in Ireland. The granules are a valuable addition to the treatment of generalised, partial and other forms of epilepsy in adults... Read more
Mircera 30mcg and 120mcg Pre Filled Syringe
01 April 2009 | New Presentations
Company: Roche Products (Ireland) Ltd. Legal Category: Prescription. HT. Sport Prohibited. Active Ingredient: Methoxy Polyethylene Glycol-Epoetin Beta 30mcg/0.3ml; 120mcg/ 0.3ml. Description: Solution for injection in a pre-filled syringe. Presentations: Pack of one pre-filled syringe, price available on request. Indication: Treatment... Read more
Prezista 400mg & 600mg
01 April 2009 | New Presentations
Hospital. Sport permitted. Janssen-Cilag Ltd is pleased to announce the launch of Prezista (darunavir) 400mg tablets and 600mg tablets. Prezista is indicated for the treatment of HIV-1 infection as part of combination therapy. In antiretroviral therapy (ART) naive adults, it... Read more
Price adjustment for Efexor/Efexor XL
01 April 2009 | New this Month
Wyeth Pharmaceuticals Ltd. wish to announce that, in accordance with the pricing agreement between IPHA and the HSE, the reimbursement price of Efexor/Efexor XL will be subject to a 20% price reduction effective 1st April 2009. It is important to... Read more
Roaccutane 5mg Soft Capsules discontinued, Roaccutane 10mg Soft Capsules launched
01 April 2009 | Discontinued Products
As part of a regular review of products in its pharmaceutical portfolio Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Roaccutane 5mg Soft Capsules. Marketing of this presentation will cease permanently on... Read more
